Indalo Therapeutics, a preclinical biotechnology company dedicated to developing therapies for fibrosis, is formed with an experienced team, strong IP, and robust portfolio of drug candidates. Learn more at www.indalotherapeutics.com.
Location: United States, Missouri, Saint Louis
Employees: 11-50
Founded date: 2014
Investors 3
Mentions in press and media 3
| Date | Title | Description | Source |
| 20.12.2019 | Bill Lundberg takes over the reins at Merus; Former Akcea ... | Bill Lundberg → Dutch biotech Merus, who struck up a $200 million bispecific development de... | endpts.com... |
| 01.02.2019 | Richard Pascoe takes the helm at Histogen; Lonza COO ste... | Richard Pascoe → Having handed off troubled microcap biotech Apricus Biosciences to Seelos... | endpts.com... |
| 28.01.2019 | The FDA is back in business; Allogene given the green si... | → FDA commish Scott Gottlieb was spreading the love Monday morning, welcoming back FDA staff ... | endpts.com... |